Anticoagulation Options: DOAC vs Left Atrial Occlusion Device is organized by American College of Osteopathic Internists (ACOI).

Release & Review Date: This activity is valid from May 13, 2023 until May 13, 2026.

Learning Objectives:
In this session, you'll learn how to:

Define the recommendations for use of Novel Oral Anticoagulants (NOACs) for treatment of Atrial Fibrillation and exclusion criteria for their use based upon the 2019 ACC/AHA/HRS Focused Update of Treatment Guidelines to Prevent Thromboembolism in Patients with Atrial Fibrillation.
Discuss the research literature that led to the Centers for Medicare Services (CMS) to adopt the National Coverage Decision for Left Atrial Appendage Occluder Device Implant and review the specific criteria that must be met for a patient to be considered eligible to receive a Left Atrial Appendage Occluder Device.
Discuss the up-to-date literature that compares Left Atrial Appendage Occlusion, Direct Oral Anticoagulants and Warfarin usage for patients with Nonvalvular Atrial Fibrillation.

Additional details will be posted as soon as information is available.